|
|
Biosimilars in Osteoporosis: Highlights from the ASBMR
Biosimilars are large, complex molecules made from living organisms that are highly similar to their reference biologic and are administered in the same way, with the same strength and dosage, and clinically meaningful differences in safety, purity, and potency.
Incorporating biosimilars into the management of osteoporosis, known as a silent chronic disease responsible for 13 million fragility fractures worldwide, provide a more affordable version of osteoporosis medication, and an alternat... |
|
|
Cleveland Clinic Children's 30th Annual Pediatric Board Review (Online Streaming & USB Formats)
Cleveland Clinic Children’s 30th Annual Pediatric Board Review is a nationally recognized, comprehensive activity that will benefit all clinicians practicing in this critical area of medicine. Primarily designed to prepare physicians for board certification or re-certification, this heavily detailed resource can help enhance clinical skills throughout the pediatric practice. A wide variety of topics are introduced in question and answer format, which highlights board relevant information and... |
|